Why the study?
Does adherence to antihypertensive drug therapy reduce cardiovascular morbidity and mortality in patients aged 85 years or older?
Does adherence to antihypertensive drug therapy reduce cardiovascular morbidity and mortality in patients aged 85 years or older?
Answers are grounded in this paper and cite their sources.
Adherence to antihypertensive therapy remains beneficial for reducing cardiovascular morbidity and mortality even in very elderly patients (≥85 years).
Adherence with antihypertensive drug therapy reduced the risk of cardiovascular morbidity in patients aged 85 years or more, the benefit including heart failure and stroke, although not MI, and extending to all-cause death.
No takes yet. Share an insight, caveat, or question.
Corrao et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: